IJMS | Free Full-Text | Molecular Epidemiology of the Main Druggable Genetic Alterations in Non-Small Cell Lung Cancer
EGFR T790M Reference Standard, mutation T790M | Genecopoeia
Figure 1 from Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer | Semantic Scholar
Identification of Activating Mutations in the Transmembrane and Extracellular Domains of EGFR | Biochemistry
Profiling of circulating tumor DNA in plasma of non‐small cell lung cancer patients, monitoring of epidermal growth factor receptor p.T790M mutated allelic fraction using beads, emulsion, amplification, and magnetics companion assay and
Treatment Options for Non-Small Cell Lung Cancer Harboring Uncommon *EGFR* Mutations | Published in healthbook TIMES Oncology Hematology
Not all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategy - Kobayashi - 2016 - Cancer Science - Wiley Online Library
Cancers | Free Full-Text | Treatment Strategies for Non-Small Cell Lung Cancer Harboring Common and Uncommon EGFR Mutations: Drug Sensitivity Based on Exon Classification, and Structure-Function Analysis
A strategy to overcome EGFR p.T790M cis p.L792F induced resistance to osimertinib - eBioMedicine
Comparison of frequencies of each EGFR mutation between our survey and... | Download Table
Pie chart showing the frequencies of EGFR mutations in NSCLC. Data was... | Download Scientific Diagram
Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer | Scientific Reports
Antitumor activity of aumolertinib, a third-generation EGFR tyrosine kinase inhibitor, in non-small-cell lung cancer harboring uncommon EGFR mutations - ScienceDirect
Cancers | Free Full-Text | Molecular Targets in Lung Cancer: Study of the Evolution of Biomarkers Associated with Treatment with Tyrosine Kinase Inhibitors—Has NF1 Tumor Suppressor a Key Role in Acquired Resistance?
Tips for Better EGFR Mutation Testing
EGFR exon 20 insertion mutations in non-small-cell lung cancer: preclinical data and clinical implications - The Lancet Oncology
Epidermal growth factor receptor mutations in lung adenocarcinoma - Laboratory Investigation
Preclinical assessment of combination therapy of EGFR tyrosine kinase inhibitors in a highly heterogeneous tumor model | Oncogene
The alteration of EGFR T790M between 19del and L858R in pre-TKI-treated... | Download Scientific Diagram
Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer | Signal Transduction and Targeted Therapy
Precision in EGFR testing
Exploring the impact of EGFR T790M neighboring SNPs on ARMS-based T790M mutation assay
Treatment Options for Non-Small Cell Lung Cancer Harboring Uncommon *EGFR* Mutations | Published in healthbook TIMES Oncology Hematology
A mechanistic analysis of the TMD activation pathways for the ABL-... | Download Scientific Diagram
Treatment Options for Non-Small Cell Lung Cancer Harboring Uncommon *EGFR* Mutations | Published in healthbook TIMES Oncology Hematology
Antitumor activity of aumolertinib, a third-generation EGFR tyrosine kinase inhibitor, in non-small-cell lung cancer harboring uncommon EGFR mutations - ScienceDirect
